Tri Locum Partners »

Alpine Immune Sciences shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 121k 39.64
2023-09-30 $3.6M 314k 11.45
2023-06-30 $3.4M 332k 10.28

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Silk Road Medical Inc Common (SILK)
Natera (NTRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Legend Biotech Corp Sponsored Ads (LEGN)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Madrigal Pharmaceuticals (MDGL)
Baxter International (BAX)
Merus N V (MRUS)
Tandem Diabetes Care Com New (TNDM)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Regeneron Pharmaceuticals (REGN)

View all positions for Tri Locum Partners

Top funds holding Alpine Immune Sciences

Decheng Capital
venBio Select Advisor
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management

View all funds holding Alpine Immune Sciences